Abstract
Introduction: Intranasal drug administration is a non-invasive method of bypassing the blood—brain barrier (BBB) to deliver therapeutic agents to the brain and spinal cord. This method also delivers those drugs that do not cross the BBB to the central nervous system (CNS) thus eliminating the need for systemic delivery, and subsequently reducing the unwanted systemic side effects. Delivery from the nose- to-brain occurs within minutes along both the olfactory and trigeminal neural pathways. Materials and Methods: Rat model was developed to determine existence of neural and non neural pathways after nasal delivery in rats. For the study mucoadhesive nanoparticles were prepared by ionic crosslinking method and the study was investigated using intranasal administration of Tc99m labeled chitosan nanoparticulate formulation in dead and alive rats. Result: The result showed a significant increase of 4.4 times radiolabeled drug concentration in the brain of live rats as compared to the radiolabeled drug concentration in the dead rats (p < 0.01). Conclusion This experimental rat model provides a proof for existence of neural and non-neural pathway for nose to brain using a novel formulation for crossing BBB which is of importance in finding a solution for neurodegenerative disorders.
Keywords: Olfactory, trigeminal, radiolabeled, nose-to-brain, nasal drug delivery, neural, non-neural
Current Nanoscience
Title: Reflection on Existence of Neural and Non-Neural Pathway for Nose- to- Brain Using a Novel Formulation of an Anticholinesterase Piperidine Derivative
Volume: 6 Issue: 3
Author(s): Javed Ali, Mushir Ali, Sanjula Baboota, Rashid Ali, Gaurav Mittal, Aseem Bhatnagar and Bhavna
Affiliation:
Keywords: Olfactory, trigeminal, radiolabeled, nose-to-brain, nasal drug delivery, neural, non-neural
Abstract: Introduction: Intranasal drug administration is a non-invasive method of bypassing the blood—brain barrier (BBB) to deliver therapeutic agents to the brain and spinal cord. This method also delivers those drugs that do not cross the BBB to the central nervous system (CNS) thus eliminating the need for systemic delivery, and subsequently reducing the unwanted systemic side effects. Delivery from the nose- to-brain occurs within minutes along both the olfactory and trigeminal neural pathways. Materials and Methods: Rat model was developed to determine existence of neural and non neural pathways after nasal delivery in rats. For the study mucoadhesive nanoparticles were prepared by ionic crosslinking method and the study was investigated using intranasal administration of Tc99m labeled chitosan nanoparticulate formulation in dead and alive rats. Result: The result showed a significant increase of 4.4 times radiolabeled drug concentration in the brain of live rats as compared to the radiolabeled drug concentration in the dead rats (p < 0.01). Conclusion This experimental rat model provides a proof for existence of neural and non-neural pathway for nose to brain using a novel formulation for crossing BBB which is of importance in finding a solution for neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Ali Javed, Ali Mushir, Baboota Sanjula, Ali Rashid, Mittal Gaurav, Bhatnagar Aseem and Bhavna , Reflection on Existence of Neural and Non-Neural Pathway for Nose- to- Brain Using a Novel Formulation of an Anticholinesterase Piperidine Derivative, Current Nanoscience 2010; 6 (3) . https://dx.doi.org/10.2174/157341310791171135
DOI https://dx.doi.org/10.2174/157341310791171135 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antiinflammatory Activity of Melatonin in Central Nervous System
Current Neuropharmacology Cyclooxygenase Enzymes: Regulation and Function
Current Pharmaceutical Design The Protective Effects of Jatrorrhizine on β-Amyloid (25-35)-Induced Neurotoxicity in Rat Cortical Neurons
CNS & Neurological Disorders - Drug Targets Discovery and Development of GSK3 Inhibitors for the Treatment of Type 2 Diabetes
Current Pharmaceutical Design A Systematic Review of Drugs in Late-Stage Development for the Treatment of Multiple Sclerosis: A Focus on Oral Synthetic Drugs
Inflammation & Allergy - Drug Targets (Discontinued) Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design Editorial:A New Journal with an Integrated Approach in the Study of Aging and Longevity
Current Aging Science Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies
Recent Patents on Anti-Cancer Drug Discovery Synthesis and Biological Interest of Structured Docosahexaenoic Acid–Containing Triacylglycerols and Phospholipids
Current Organic Chemistry Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration
Current Drug Targets Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)
Current Medicinal Chemistry Targeting SUMOylation Cascade for Diabetes Management
Current Drug Targets <i>Arctium Lappa</i> and Management of Liver Functions to Detoxify the Bloodstream
The Natural Products Journal Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry The Role of Inflammation in Neurological Disorders
Current Pharmaceutical Design Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
Current Alzheimer Research Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
CNS & Neurological Disorders - Drug Targets Immunophilin Dysfunction and Neuropathology
Current Medicinal Chemistry The Potential Use of Hormone-Based Therapeutics for the Treatment of Alzheimers Disease
Current Alzheimer Research Strategic Selection of Neuroinflammatory Models in Parkinson's Disease: Evidence from Experimental Studies
CNS & Neurological Disorders - Drug Targets